��ϳԹ�

JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
About Us
News

News

Learn about key ��ϳԹ� news by reading press releases, as well as mentions of us by external media outlets.

��ϳԹ� Brings Groundbreaking Intestinal and Brain Organoid Culture Tools to the Global Research Community

01/10/2018
��ϳԹ� Signs Exclusive License with Propagenix to Commercialize EpiX™, an Innovation Empowering Epithelial Cell Biology and Cell Therapy

09/20/2017
How the Global Talent Stream Can Improve Vancouver’s Biotechnology Sector

06/22/2017
��ϳԹ� to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells

03/29/2017
��ϳԹ� Opens New Office and Laboratories in Cambridge, UK

01/31/2017
��ϳԹ� Signs Exclusive License Agreement with Cincinnati Children’s for Stem Cell-Derived Organoid Technology

12/19/2016
��ϳԹ� Signs Exclusive Agreement with the Institute of Molecular Biotechnology to Commercialize Cerebral Organoid Culture Systems

04/13/2016
��ϳԹ� Inc. Obtains License from iPS Academia Japan for Induced Pluripotent Stem Cell Technologies

08/25/2015
Lawson and ��ϳԹ� Announce Partnership for Commercialization of Tools for Parkinson's Disease Research

08/20/2015
��ϳԹ� Launches Innovative Products to Support CAR T Cell Research

06/30/2015
��ϳԹ� to Commercialize BrainPhys™ Neuronal Culture Medium for Improved Support of Neurophysiological Activity

05/05/2015
��ϳԹ� wins Support from Western Innovation (WINN) Initiative for Commercialization of 3D Cell Culture Platform

09/09/2014

Copyright © 2025 by ��ϳԹ�. All rights reserved.